Insufficient scRNA-seq data for expression of ERVMER34-1 at single-cell level.
Insufficient scRNA-seq data for expression of ERVMER34-1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 98.52 | 563 / 578 | 80% | 7.39 | 925 / 1155 |
ovary | 99% | 211.07 | 179 / 180 | 76% | 3.19 | 328 / 430 |
prostate | 87% | 35.89 | 213 / 245 | 86% | 2.73 | 430 / 502 |
esophagus | 71% | 72.60 | 1024 / 1445 | 90% | 10.88 | 164 / 183 |
uterus | 74% | 42.34 | 125 / 170 | 87% | 8.62 | 399 / 459 |
pancreas | 92% | 49.32 | 303 / 328 | 66% | 1.91 | 117 / 178 |
breast | 65% | 39.36 | 299 / 459 | 88% | 5.23 | 979 / 1118 |
stomach | 92% | 48.96 | 331 / 359 | 58% | 3.01 | 165 / 286 |
bladder | 67% | 38.05 | 14 / 21 | 78% | 6.00 | 393 / 504 |
brain | 84% | 36.69 | 2211 / 2642 | 38% | 0.76 | 270 / 705 |
intestine | 65% | 20.46 | 632 / 966 | 55% | 2.73 | 292 / 527 |
adrenal gland | 100% | 65.93 | 257 / 258 | 18% | 0.62 | 42 / 230 |
skin | 96% | 60.01 | 1740 / 1809 | 20% | 1.40 | 93 / 472 |
kidney | 100% | 202.52 | 89 / 89 | 15% | 0.47 | 138 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.62 | 1 / 1 |
spleen | 98% | 79.58 | 236 / 241 | 0% | 0 | 0 / 0 |
thymus | 82% | 38.25 | 538 / 653 | 14% | 0.31 | 85 / 605 |
heart | 94% | 131.14 | 807 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 8.85 | 39 / 45 |
adipose | 36% | 9.19 | 437 / 1204 | 0% | 0 | 0 / 0 |
liver | 16% | 5.47 | 37 / 226 | 18% | 0.94 | 72 / 406 |
eye | 0% | 0 | 0 / 0 | 29% | 0.91 | 23 / 80 |
blood vessel | 28% | 7.24 | 373 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 0.41 | 20 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.16 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
Gene name | ERVMER34-1 |
Protein name | Endogenous retroviral envelope protein HEMO (Endogenous retrovirus group MER34 member 1 Env polyprotein) (HERV-MER_4q12 provirus ancestral Env polyprotein) (Human endogenous MER34 (medium-reiteration-frequency-family-34) open reading frame) (Human endogenous MER34 ORF) (HEMO) [Cleaved into: Endogenous retroviral envelope protein HEMO, secreted form (Endogenous retroviral envelope protein HEMO, 48 kDa form)] |
Synonyms | LP9056 HEMO |
Description | FUNCTION: Endogenous envelope proteins originate from retroviral envelope proteins, which mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. . |
Accessions | Q9H9K5 ENST00000440542.1 ENST00000443173.6 |